Background There is interest in whether a short course of combination antiretroviral therapy
(cART) at the time of human immunodeficiency virus (HIV) seroconversion could induce long-
term immunologic control after its interruption. We aimed to determine the time of virologic
rebound after interruption of treatment initiated close to HIV seroconversion and to identify
potential cases of posttreatment controllers (PTCs) in the CASCADE (Concerted Action on
Seroconversion to AIDS and Death in Europe) Collaboration. Methods Prospective cohort …